has announced that a wireless device developed by his brain chip company Neuralink is expected to begin human clinical trials in six months, and one of its first targeted applications is restoring vision. The new CEO held a 'Show and Tell' event on Wednesday where he spoke about how the brain chip interfaces could enable disabled patients to move and communicate again.'It's like replacing a piece of the skull with a smartwatch,' he said.
Load More
Load More